1. Home
  2. POAI vs AQB Comparison

POAI vs AQB Comparison

Compare POAI & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • AQB
  • Stock Information
  • Founded
  • POAI 2002
  • AQB 1991
  • Country
  • POAI United States
  • AQB United States
  • Employees
  • POAI N/A
  • AQB N/A
  • Industry
  • POAI Industrial Specialties
  • AQB
  • Sector
  • POAI Health Care
  • AQB
  • Exchange
  • POAI Nasdaq
  • AQB Nasdaq
  • Market Cap
  • POAI 4.9M
  • AQB 4.4M
  • IPO Year
  • POAI N/A
  • AQB N/A
  • Fundamental
  • Price
  • POAI $0.69
  • AQB $1.00
  • Analyst Decision
  • POAI Hold
  • AQB Hold
  • Analyst Count
  • POAI 1
  • AQB 2
  • Target Price
  • POAI N/A
  • AQB N/A
  • AVG Volume (30 Days)
  • POAI 119.5K
  • AQB 14.5K
  • Earning Date
  • POAI 11-12-2024
  • AQB 11-05-2024
  • Dividend Yield
  • POAI N/A
  • AQB N/A
  • EPS Growth
  • POAI N/A
  • AQB N/A
  • EPS
  • POAI N/A
  • AQB N/A
  • Revenue
  • POAI $1,484,223.00
  • AQB $1,258,512.00
  • Revenue This Year
  • POAI N/A
  • AQB N/A
  • Revenue Next Year
  • POAI $502.91
  • AQB $57.86
  • P/E Ratio
  • POAI N/A
  • AQB N/A
  • Revenue Growth
  • POAI N/A
  • AQB N/A
  • 52 Week Low
  • POAI $0.55
  • AQB $0.82
  • 52 Week High
  • POAI $3.76
  • AQB $4.03
  • Technical
  • Relative Strength Index (RSI)
  • POAI 44.88
  • AQB 36.74
  • Support Level
  • POAI $0.70
  • AQB $1.01
  • Resistance Level
  • POAI $0.89
  • AQB $1.11
  • Average True Range (ATR)
  • POAI 0.11
  • AQB 0.04
  • MACD
  • POAI 0.00
  • AQB -0.02
  • Stochastic Oscillator
  • POAI 14.64
  • AQB 0.00

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

Share on Social Networks: